Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SELLAS Life Sciences (SLS) Return on Sales (2020 - 2022)

SELLAS Life Sciences (SLS) has disclosed Return on Sales for 3 consecutive years, with 41.95% as the latest value for Q4 2022.

  • Quarterly Return on Sales fell 3862.0% to 41.95% in Q4 2022 from the year-ago period, while the trailing twelve-month figure was 41.95% through Dec 2022, down 3862.0% year-over-year, with the annual reading at 41.3% for FY2022, 3858.0% down from the prior year.
  • Return on Sales for Q4 2022 was 41.95% at SELLAS Life Sciences, up from 44.12% in the prior quarter.
  • The five-year high for Return on Sales was 0.39% in Q1 2021, with the low at 44.12% in Q3 2022.
  • Average Return on Sales over 3 years is 17.43%, with a median of 3.33% recorded in 2021.
  • The sharpest move saw Return on Sales tumbled -114bps in 2021, then crashed -4225bps in 2022.
  • Over 3 years, Return on Sales stood at 2.19% in 2020, then crashed by -52bps to 3.33% in 2021, then tumbled by -1160bps to 41.95% in 2022.
  • According to Business Quant data, Return on Sales over the past three periods came in at 41.95%, 44.12%, and 43.95% for Q4 2022, Q3 2022, and Q2 2022 respectively.